相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
Hugh Calkins et al.
EUROPACE (2019)
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
Stefan H. Hohnloser et al.
EUROPEAN HEART JOURNAL (2019)
Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
Stefan H. Hohnloser et al.
CLINICAL CARDIOLOGY (2018)
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2018)
Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin
Hirosuke Yamaji et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2018)
Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation: Understanding the Gaps in Evidence
Anne-Celine Martin et al.
CIRCULATION (2018)
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Hugh Calkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Hirosuke Yamaji et al.
CLINICAL DRUG INVESTIGATION (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPACE (2016)
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
Riccardo Cappato et al.
EUROPEAN HEART JOURNAL (2015)
Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
Luigi Di Biase et al.
HEART RHYTHM (2015)
Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation
Tomoyuki Nagao et al.
HEART RHYTHM (2015)
Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
Mohamed Bassiouny et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design
Hugh Calkins et al.
EUROPACE (2012)
Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Joanne van Ryn et al.
THROMBOSIS AND HAEMOSTASIS (2010)
分享论文
